SI-BONE Shares Rise 19% on Expected Higher 4Q, Full-Year Revenue

Dow Jones
Jan 14
 

By Stephen Nakrosis

 

Shares of SI-BONE were higher after the medical-device company released some preliminary financial results for the fourth quarter and full year 2024.

The company's shares were up 19%, to $16.34, by early Monday afternoon.

For the fourth quarter, SI-BONE said it was expecting worldwide revenue in the range of $48.8 million to $49 million. In the prior fourth quarter, the company reported revenue of $38.9 million.

The company also said it was expecting 2024 worldwide revenue between $167 million and $167.1 million, above the previous guidance of $165 million to $166 million.

 

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

January 13, 2025 13:48 ET (18:48 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10